<DOC>
	<DOCNO>NCT00395746</DOCNO>
	<brief_summary>This trial conduct Japan . The trial aim comparison effect glycaemic control liraglutide combination sulphonylurea agent ( SU ) compare SU monotherapy , assess HbA1c 24 week 52 week subject type 2 diabetes . Liraglutide compare placebo , combination SU . Trial randomisation period 24 week follow 28 week extension period , total 52 week .</brief_summary>
	<brief_title>Effect Liraglutide Combination With Sulfonylurea ( SU ) Blood Glucose Control Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes Diet/exercise therapy sulfonylurea ( SU ) least eight week HbA1c great equal 7.0 % le 10.0 % BMI le 35 kg/m2 Treatment insulin within last 12 week Treatment drug could interfere glucose level Any serious medical condition Females pregnant , intention become pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>